Nadiminty N - Search Results

1

Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.

Nadiminty N, Dutt S, Tepper C, Gao AC. Nadiminty N, et al. Prostate. 2010 Feb 15;70(3):276-87. doi: 10.1002/pros.21062. Prostate. 2010. PMID: 19827050

2

Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.

Lee SO, Lou W, Nadiminty N, Lin X, Gao AC. Lee SO, et al. Among authors: nadiminty n. Prostate. 2005 Jul 1;64(2):160-7. doi: 10.1002/pros.20218. Prostate. 2005. PMID: 15678501

3

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC. Lee SO, et al. Among authors: nadiminty n. Prostate. 2006 Jul 1;66(10):1070-5. doi: 10.1002/pros.20329. Prostate. 2006. PMID: 16637076

4

Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.

Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC. Lee SO, et al. Among authors: nadiminty n. Prostate. 2007 May 15;67(7):764-73. doi: 10.1002/pros.20553. Prostate. 2007. PMID: 17373716

5

NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.

Nadiminty N, Chun JY, Lou W, Lin X, Gao AC. Nadiminty N, et al. Prostate. 2008 Dec 1;68(16):1725-33. doi: 10.1002/pros.20839. Prostate. 2008. PMID: 18781579

6

Interleukin-4 activates androgen receptor through CBP/p300.

Lee SO, Chun JY, Nadiminty N, Lou W, Feng S, Gao AC. Lee SO, et al. Among authors: nadiminty n. Prostate. 2009 Feb 1;69(2):126-32. doi: 10.1002/pros.20865. Prostate. 2009. PMID: 18819102 Free PMC article.

7

Interleukin-6 regulates androgen synthesis in prostate cancer cells.

Chun JY, Nadiminty N, Dutt S, Lou W, Yang JC, Kung HJ, Evans CP, Gao AC. Chun JY, et al. Among authors: nadiminty n. Clin Cancer Res. 2009 Aug 1;15(15):4815-22. doi: 10.1158/1078-0432.CCR-09-0640. Epub 2009 Jul 28. Clin Cancer Res. 2009. PMID: 19638459 Free PMC article.

8

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

Nadiminty N, Lou W, Sun M, Chen J, Yue J, Kung HJ, Evans CP, Zhou Q, Gao AC. Nadiminty N, et al. Cancer Res. 2010 Apr 15;70(8):3309-19. doi: 10.1158/0008-5472.CAN-09-3703. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388792 Free PMC article.

9

Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.

Sun M, Liu C, Nadiminty N, Lou W, Zhu Y, Yang J, Evans CP, Zhou Q, Gao AC. Sun M, et al. Among authors: nadiminty n. Prostate. 2012 Jan;72(1):82-9. doi: 10.1002/pros.21409. Epub 2011 May 2. Prostate. 2012. PMID: 21538419 Free PMC article.

10

RhoGDIα suppresses growth and survival of prostate cancer cells.

Zhu Y, Tummala R, Liu C, Nadiminty N, Lou W, Evans CP, Zhou Q, Gao AC. Zhu Y, et al. Among authors: nadiminty n. Prostate. 2012 Mar;72(4):392-8. doi: 10.1002/pros.21441. Epub 2011 Jun 16. Prostate. 2012. PMID: 21681778 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters